IINN
Inspira Technologies Oxy BHN Ltd
NASDAQ: IINN · HEALTHCARE · MEDICAL DEVICES
$0.44
-0.90% today
Updated 2026-04-30
Market cap
$22.18M
P/E ratio
—
P/S ratio
76.75x
EPS (TTM)
$-0.45
Dividend yield
—
52W range
$0 – $2
Volume
0.3M
Inspira Technologies Oxy BHN Ltd (IINN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $-4.68M | $0.00 | $0.00 | $289000.00 |
| Revenue growth (YoY) | — | — | — | — | — | +100.0% | — | — |
| Cost of revenue | — | $76000.00 | $203000.00 | $218000.00 | $361000.00 | $406000.00 | $488000.00 | $561000.00 |
| Gross profit | — | $-76000.00 | $-203000.00 | $-218000.00 | $-5.04M | $-406000.00 | $-488000.00 | $-272000.00 |
| Gross margin | — | — | — | — | 107.7% | — | — | -94.1% |
| R&D | $26400.00 | $887000.00 | $3.87M | $3.91M | $8.05M | $7.03M | $6323.00 | $7.16M |
| SG&A | $13200.00 | $359000.00 | $2.44M | $7.40M | $5.39M | $3.69M | $3.79M | $5.88M |
| Operating income | $-39600.00 | $-1.27M | $-6.27M | $-12.17M | $14.89M | $-12.13M | $11267.00 | $-13.61M |
| Operating margin | — | — | — | — | -318.4% | — | — | -4710.7% |
| EBITDA | — | $-4.49M | $-6.96M | $-16.72M | $-14.68M | $-10.87M | $-11096.00 | $-13.16M |
| EBITDA margin | — | — | — | — | 313.9% | — | — | -4555.4% |
| EBIT | $-39600.00 | $-4.57M | $-7.16M | $-16.94M | $-14.98M | $-11.28M | $-11267.00 | $-13.61M |
| Interest expense | $0.00 | $9000.00 | $5000.00 | $6000.00 | $181000.00 | $10000.00 | — | $9000.00 |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-39600.00 | $-4.58M | $-7.23M | $-16.96M | $-4.00M | $-11.29M | $-11053.00 | $-13.22M |
| Net income growth (YoY) | — | -11475.8% | -57.8% | -134.5% | +76.4% | -182.0% | +99.9% | -119505.5% |
| Profit margin | — | — | — | — | 85.5% | — | — | -4574.4% |